Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are actually involved in the disease mechanisms? An international team led by Helmholtz Munich has now used ...
Jan 29, 2026
0
17
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes ...
Mar 10, 2026
0
17
The month of Ramadan, which began last week, is when many Muslims around the world fast from dawn to sunset, refraining from food, drink, and other physical needs as an act of worship and self-discipline.
Mar 1, 2026
0
17
A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for type 2 diabetes and obesity, finds they are associated with ...
Apr 17, 2026
0
17
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health and reduce ...
Jan 28, 2026
0
17
People who live with obesity are "tagging" a memory of being overweight on a key part of the immune system—leaving people with ongoing risk of obesity-related conditions years after losing weight, according to a 10-year-long ...
Apr 27, 2026
0
17
An AI can accurately diagnose a rare endocrinological condition just by analyzing pictures of the back of the hand and the clenched fist. The privacy-conscious achievement by Kobe University holds promise for establishing ...
Feb 27, 2026
0
17
A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signaling pathway as a "door ...
Apr 29, 2026
0
16
A global effort led by Monash University has changed the name of a significant women's health condition that was misunderstood to be "all about ovarian cysts." Polyendocrine metabolic ovarian syndrome (PMOS) is the new name ...
May 12, 2026
0
16
A new electronic implant system can help lab-grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes. The approach, developed by researchers at the Perelman ...
Feb 19, 2026
0
19
